Table: Rohto -Q1 group results

Rohto Pharmaceutical

09/08/2018 07:00

Aug 9 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               40.64               35.84           176.00    
                   (+13.4 pct)         (+9.0 pct)       (+2.5 pct)  
  Operating            5.06                3.43            19.50    
                   (+47.4 pct)         (+54.9 pct)      (+2.2 pct)  
  Recurring            5.29                3.60            19.60    
                   (+47.1 pct)         (+48.0 pct)      (+4.0 pct)  
  Net                  3.44                2.28            11.90    
                   (+51.2 pct)         (+65.7 pct)      (+28.1 pct) 
  EPS               30.20 yen           19.98 yen       104.42 yen  
  EPS Diluted       30.07 yen           19.89 yen                   
  Ann Div                               22.00 yen        23.00 yen  
  -Q2 div                               11.00 yen        11.00 yen  
  -Q4 div                               11.00 yen        12.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T